Free Trial

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Short Interest Down 84.5% in February

EssilorLuxottica logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Short interest plunged 84.5% to 1,733 shares as of Feb. 27 (down from 11,183 on Feb. 12), representing effectively 0.0% of shares shorted and a short-interest ratio of 0.0 days based on average daily volume.
  • OTCMKTS:ESLOY traded at $122.50 (down $0.25) on the day with volume below average, sitting well under its 50‑day ($149.64) and 200‑day ($161.70) moving averages and within a 52‑week range of $118.51–$186.81.
  • Analyst sentiment is positive: recent upgrades (including UBS to strong‑buy and multiple buy ratings) leave the stock with an average MarketBeat rating of "Buy".
  • MarketBeat previews top five stocks to own in May.

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY - Get Free Report) was the target of a significant decline in short interest in February. As of February 27th, there was short interest totaling 1,733 shares, a decline of 84.5% from the February 12th total of 11,183 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 371,108 shares, the short-interest ratio is currently 0.0 days. Based on an average daily volume of 371,108 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.

EssilorLuxottica Stock Down 0.2%

OTCMKTS:ESLOY traded down $0.25 during trading hours on Tuesday, hitting $122.50. The company had a trading volume of 108,641 shares, compared to its average volume of 122,031. EssilorLuxottica has a 1 year low of $118.51 and a 1 year high of $186.81. The company has a 50-day moving average of $149.64 and a 200 day moving average of $161.70. The company has a quick ratio of 0.67, a current ratio of 0.97 and a debt-to-equity ratio of 0.18.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on ESLOY shares. UBS Group upgraded EssilorLuxottica from a "hold" rating to a "strong-buy" rating in a report on Thursday, November 27th. Kepler Capital Markets raised EssilorLuxottica from a "hold" rating to a "buy" rating in a report on Thursday, January 15th. Citigroup reaffirmed a "buy" rating on shares of EssilorLuxottica in a research note on Thursday, December 11th. Zacks Research cut EssilorLuxottica from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, November 18th. Finally, The Goldman Sachs Group reissued a "buy" rating on shares of EssilorLuxottica in a research note on Friday, December 5th. Two research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Buy".

Read Our Latest Analysis on EssilorLuxottica

About EssilorLuxottica

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company's product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EssilorLuxottica Right Now?

Before you consider EssilorLuxottica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EssilorLuxottica wasn't on the list.

While EssilorLuxottica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines